Investigation of neuroprotective and antiapoptotic effects of rosmarinic acid in an in vitro Alzheimer’s disease model

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 57

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-29-8_010

تاریخ نمایه سازی: 14 مرداد 1405

چکیده مقاله:

Objective(s): Rosmarinic acid (RA) exhibits anti-oxidant, anti-aging, and anti-inflammatory properties. This study aimed to investigate the effects of RA on amyloid beta (Aβ), phosphorylated tau (p-tau), α-synuclein (α-syn), Abelson tyrosine kinase (Abl), and apoptotic markers in an in vitro Alzheimer’s disease (AD) model.Materials and Methods: SH-SY۵Y cells were differentiated into cholinergic neurons by all-trans retinoic acid (ATRA). CCK-۸ assay was performed to determine the concentrations of Aβ, RA, and Aβ+RA on differentiated cells (D-cholinergic neurons). Then, control (D), D+Aβ, pretreatment (D+Aβ+RA), and D+RA groups were formed. Gene expression levels of apoptotic biomarkers were evaluated using qRT-PCR. Aβ, α-syn, Abl, p-tau, caspase-۷ (CASP۷), BAX, and cytochrome c (CYCS) protein levels were determined by ELISA. Results: CCK-۸ assay showed that RA (۰.۵–۵ µM) was non-toxic to differentiated cells, and the IC₄₀ of Aβ₁₋₄₂ was ۲۰ µM. Pretreatment with ۱.۵ µM RA protected cells from Aβ-induced toxicity. Gene expression analysis revealed that apoptotic markers (BAX, BLC۲, CYCS, CASP۳, CASP۷, FAS, FADD) were significantly increased in the D+Aβ group compared to the control, whereas their levels were markedly reduced in the D+Aβ+RA group relative to the D+Aβ group. ELISA results corroborated qRT-PCR findings for CASP۷, BAX, and CYCS. Additionally, RA decreased Aβ, α-syn, and p-tau protein levels, while Abl levels increased only in the D+RA group.Conclusion: RA exhibits neuroprotective and antiapoptotic effects by modulating apoptotic markers and reducing pathological proteins in an in vitro AD model.

نویسندگان

Aysu Şen

Necmettin Erbakan University, Faculty of Medicine, Department of Physiology, Konya, Turkey

Canan Eroğlu Güneş

Necmettin Erbakan University, Faculty of Medicine, Department of Medical Biology, Konya, Turkey

Ebru Nur Dursun

Necmettin Erbakan University, Faculty of Medicine, Department of Medical Biology, Konya, Turkey

Ercan Kurar

Necmettin Erbakan University, Faculty of Medicine, Department of Medical Biology, Konya, Turkey

Selim Kutlu

Necmettin Erbakan University, Faculty of Medicine, Department of Physiology, Konya, Turkey

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Thingore C, Kshirsagar V, Juvekar A. Amelioration of oxidative stress ...
  • Vaz M, Silvestre S. Alzheimer’s disease: Recent treatment strategies. Eur ...
  • Lista S, Vergallo A, Teipel SJ, Lemercier P, Giorgi FS, ...
  • Holtzman DM, Carrillo MC, Hendrix JA, Bain LJ, Catafau AM, ...
  • Yang M, Zhang X, Qiao O, Ji H, Zhang Y, ...
  • Ferlemi A-V, Katsikoudi A, Kontogianni VG, Kellici TF, Iatrou G, ...
  • Lee AY, Hwang BR, Lee MH, Lee S, Cho EJ. ...
  • Gutierrez DA, Vargas LM, Chandia-Cristi A, De la Fuente C, ...
  • Zhu Q, Chen J, Wu X, Jin X, Ruan B. ...
  • Pardridge WM. Alzheimer’s disease drug development and the problem of ...
  • Senior K. Gleevec does not cross blood–brain barrier. Lancet Oncol ...
  • Porkka K, Koskenvesa P, Lundán T, Rimpiläinen J, Mustjoki S, ...
  • Chi H, Chang H-Y, Sang T-K. Neuronal cell death mechanisms ...
  • Mirza FJ, Zahid S. Ursolic acid and rosmarinic acid ameliorate ...
  • نمایش کامل مراجع